|
FR2260330A1
(en)
|
1974-02-07 |
1975-09-05 |
Innothera Lab Sa |
Pyridoxine N-oxy nicotinate - hypolipaemiant and hypocholesterolemiant of good therapeutic index
|
|
US4032526A
(en)
|
1975-10-02 |
1977-06-28 |
American Cyanamid Company |
1,2-dimethyl-3 or 5-piperazinyl-pyrazolium salts
|
|
GB2068961B
(en)
|
1980-02-13 |
1983-11-30 |
Sankyo Co |
Quinazoline derivatives
|
|
DE3517617A1
(de)
|
1985-05-15 |
1986-11-20 |
Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München |
Neue pyridaziniumverbindungen, verfahren zu deren herstellung und diese enthaltende fungizide und algizide mittel
|
|
DE69325662T2
(de)
|
1992-10-23 |
2000-02-10 |
Merck Sharp & Dohme Ltd., Hoddesdon |
Dopamin rezeptor subtyp liganden
|
|
US5629325A
(en)
|
1996-06-06 |
1997-05-13 |
Abbott Laboratories |
3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission
|
|
US6979686B1
(en)
|
2001-12-07 |
2005-12-27 |
Pharmacia Corporation |
Substituted pyrazoles as p38 kinase inhibitors
|
|
US6514977B1
(en)
|
1997-05-22 |
2003-02-04 |
G.D. Searle & Company |
Substituted pyrazoles as p38 kinase inhibitors
|
|
ATE491689T1
(de)
|
1997-10-27 |
2011-01-15 |
Neurosearch As |
Heteroaryl diazacycloalkane als cholinergische ligande für nikotin-acetylcholin-rezeptoren
|
|
US6143892A
(en)
|
1998-11-20 |
2000-11-07 |
G. D. Searle & Co. |
Process for making 5-substituted pyrazoles
|
|
US6248755B1
(en)
|
1999-04-06 |
2001-06-19 |
Merck & Co., Inc. |
Pyrrolidine modulators of chemokine receptor activity
|
|
CA2371583C
(en)
|
1999-05-04 |
2005-09-13 |
Schering Corporation |
Piperazine derivatives useful as ccr5 antagonists
|
|
GB0004153D0
(en)
|
2000-02-23 |
2000-04-12 |
Astrazeneca Uk Ltd |
Novel use
|
|
DZ3347A1
(fr)
|
2000-05-22 |
2001-11-29 |
Aventis Pharma Inc |
Dérivés d'arylméthylamine pour leur utilisation comme inhibiteurs de la tryptase
|
|
CN100519558C
(zh)
|
2000-10-12 |
2009-07-29 |
贝林格尔英格海姆法玛两合公司 |
结晶单水合物、其制备方法及其在制备药物组合中的用途
|
|
AR035700A1
(es)
|
2001-05-08 |
2004-06-23 |
Astrazeneca Ab |
Derivados de arilheteroalquilamina, composicion farmaceutica, usos de estos derivados para la fabricacion de medicamentos, metodos de tratamiento, y proceso para la preparacion de estos derivados
|
|
CZ302786B6
(cs)
|
2001-06-22 |
2011-11-09 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Krystalický bezvodý tiotropiumbromid, zpusob jeho výroby a jeho použití pro výrobu léciva pro lécbu asthmatu
|
|
AU2002363236A1
(en)
|
2001-10-30 |
2003-05-12 |
Millennium Pharmaceuticals, Inc. |
Compounds, pharmaceutical compositions and methods of use therefor
|
|
US6806279B2
(en)
|
2001-12-17 |
2004-10-19 |
Sunesis Pharmaceuticals, Inc. |
Small-molecule inhibitors of interleukin-2
|
|
AU2003203148A1
(en)
|
2002-02-05 |
2003-09-02 |
High Point Pharmaceuticals, Llc |
Novel aryl- and heteroarylpiperazines
|
|
HUP0200849A2
(hu)
|
2002-03-06 |
2004-08-30 |
Sanofi-Synthelabo |
N-aminoacetil-2-ciano-pirrolidin-származékok, e vegyületeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
|
|
ES2306859T3
(es)
|
2002-03-13 |
2008-11-16 |
Janssen Pharmaceutica Nv |
Derivados de sulfonil como nuevos inhibidores de histona deacetilasa.
|
|
US20040014744A1
(en)
|
2002-04-05 |
2004-01-22 |
Fortuna Haviv |
Substituted pyridines having antiangiogenic activity
|
|
EP1501507B1
(en)
*
|
2002-04-29 |
2008-05-28 |
Merck & Co., Inc. |
Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity
|
|
US20040082551A1
(en)
|
2002-06-05 |
2004-04-29 |
Benson Alan G. |
Novel pyrazoles and their use as p38 kinase inhibitors
|
|
WO2004024710A1
(en)
|
2002-09-13 |
2004-03-25 |
Glaxo Group Limited |
Urea compounds active as vanilloid receptor antagonists for the treatment of pain
|
|
SE0203304D0
(sv)
|
2002-11-07 |
2002-11-07 |
Astrazeneca Ab |
Novel Coumpounds
|
|
GB0229618D0
(en)
|
2002-12-19 |
2003-01-22 |
Cancer Rec Tech Ltd |
Pyrazole compounds
|
|
WO2004074438A2
(en)
|
2003-02-14 |
2004-09-02 |
Smithkline Beecham Corporation |
Ccr8 antagonists
|
|
BRPI0408284B8
(pt)
|
2003-03-12 |
2021-05-25 |
Kudos Pharm Ltd |
compostos derivados de ftalazinona, seu uso e composição farmacêutica compreendendo os mesmos
|
|
PL1615909T3
(pl)
|
2003-04-23 |
2009-01-30 |
Glaxo Group Ltd |
Pochodne piperazyny i ich zastosowanie w leczeniu chorób neurologicznych i psychicznych
|
|
FR2854158B1
(fr)
|
2003-04-25 |
2006-11-17 |
Sanofi Synthelabo |
Derives de 2-acylamino-4-phenylethiazole, leur preparation et leur application en therapeutique
|
|
WO2005014571A1
(en)
|
2003-07-18 |
2005-02-17 |
Glaxo Group Limited |
Substituted piperidines as histamine h3 receptor ligands
|
|
DK1651615T3
(da)
*
|
2003-07-29 |
2010-05-25 |
High Point Pharmaceuticals Llc |
Pyridazinyl-piperaziner og anvendelse deraf som histamin-H3-receptorligander
|
|
BRPI0417605B8
(pt)
|
2003-12-18 |
2021-05-25 |
Incyte Corp |
n-[2-((3s)-3-{[4-hidróxi-4-(5-pirimidin-2- ilpiridin-2-il)ciclohexil]amino}-pirrolidin-1-il)-2- oxoetil]-3-(trifluor-metil)benzamida, ou um sal farmaceuticamente aceitável do mesmo e composição que o compreende.
|
|
US7435830B2
(en)
|
2004-03-03 |
2008-10-14 |
Chemocentryx, Inc. |
Bicyclic and bridged nitrogen heterocycles
|
|
AU2005230902A1
(en)
|
2004-03-31 |
2005-10-20 |
Janssen Pharmaceutica, N.V. |
Non-imidazole heterocyclic compounds as histamine H3-receptor ligands
|
|
WO2005117909A2
(en)
|
2004-04-23 |
2005-12-15 |
Exelixis, Inc. |
Kinase modulators and methods of use
|
|
WO2006001958A2
(en)
|
2004-05-21 |
2006-01-05 |
Merck & Co., Inc. |
Amino cyclopentyl heterocyclic and carbocyclic modulators of chemokine receptor activity
|
|
WO2005118588A1
(ja)
|
2004-06-02 |
2005-12-15 |
Takeda Pharmaceutical Company Limited |
縮合複素環化合物
|
|
US8071624B2
(en)
|
2004-06-24 |
2011-12-06 |
Incyte Corporation |
N-substituted piperidines and their use as pharmaceuticals
|
|
WO2006012135A1
(en)
|
2004-06-24 |
2006-02-02 |
Janssen Pharmaceutica, N. V. |
Quaternary salt ccr2 antagonists
|
|
WO2006004741A2
(en)
|
2004-06-28 |
2006-01-12 |
Incyte Corporation |
3-aminocyclopentanecarboxamides as modulators of chemokine receptors
|
|
CA2577191A1
(en)
|
2004-08-26 |
2006-03-02 |
Kudos Pharmaceuticals Limited |
4-heteroarylmethyl substituted phthalazinone derivatives
|
|
GB0420831D0
(en)
|
2004-09-17 |
2004-10-20 |
Glaxo Group Ltd |
Novel compounds
|
|
GB0421525D0
(en)
|
2004-09-28 |
2004-10-27 |
Novartis Ag |
Inhibitors of protein kineses
|
|
WO2006038734A1
(en)
|
2004-10-08 |
2006-04-13 |
Astellas Pharma Inc. |
Pyridazinone derivatives cytokines inhibitors
|
|
JP5337375B2
(ja)
|
2004-11-02 |
2013-11-06 |
ノースウェスタン ユニバーシティ |
ピリダジン化合物、組成物および方法
|
|
DE102004061751A1
(de)
|
2004-12-22 |
2006-07-06 |
Bayer Healthcare Ag |
Cyanoguanidin-substituierte Pyrazoline
|
|
ES2528674T3
(es)
|
2005-02-17 |
2015-02-11 |
Astellas Pharma Inc. |
Piperidina y carboxilatos de piperacina como inhibidores de FAAH
|
|
US20070032475A1
(en)
|
2005-04-15 |
2007-02-08 |
Ye Xiaocong M |
Novel compounds useful for bradykinin B1 receptor antagonism
|
|
CA2606288A1
(en)
|
2005-04-18 |
2006-10-26 |
Neurogen Corporation |
Subtituted heteroaryl cb1 antagonists
|
|
WO2006127587A1
(en)
|
2005-05-20 |
2006-11-30 |
Vertex Pharmaceuticals Incorporated |
Pyrrolopyridines useful as inhibitors of protein kinase
|
|
RU2499795C2
(ru)
|
2005-07-04 |
2013-11-27 |
Хай Пойнт Фармасьютикалс, ЛЛС |
Антагонисты гистаминовых н3-рецепторов
|
|
US7851474B2
(en)
|
2005-08-02 |
2010-12-14 |
Neurogen Corporation |
Dipiperazinyl ketones and related analogues
|
|
GB0517184D0
(en)
|
2005-08-22 |
2005-09-28 |
Glaxo Group Ltd |
Compounds
|
|
AR055203A1
(es)
|
2005-08-31 |
2007-08-08 |
Otsuka Pharma Co Ltd |
Derivados de benzotiofeno con propiedades antipsicoticas
|
|
EP1928236B1
(en)
|
2005-09-27 |
2011-11-23 |
Irm Llc |
Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptors
|
|
WO2007053498A1
(en)
|
2005-11-01 |
2007-05-10 |
Millennium Pharmaceuticals, Inc. |
Compounds useful as antagonists of ccr2
|
|
WO2007053495A2
(en)
|
2005-11-01 |
2007-05-10 |
Millennium Pharmaceuticals, Inc. |
Compounds useful as antagonists of ccr2
|
|
RU2008123388A
(ru)
|
2005-11-14 |
2009-12-27 |
Айрм Ллк (Bm) |
Соединения и композиции в качестве модуляторов lxr
|
|
WO2007084868A2
(en)
|
2006-01-17 |
2007-07-26 |
Kalypsys, Inc. |
Treatment of disorders by activation of the unfolded protein response
|
|
JO2660B1
(en)
|
2006-01-20 |
2012-06-17 |
نوفارتيس ايه جي |
Pi-3 inhibitors and methods of use
|
|
CN101484424B
(zh)
|
2006-02-28 |
2014-05-14 |
达特神经科学(开曼)有限公司 |
治疗化合物
|
|
EP2024353A2
(en)
|
2006-03-16 |
2009-02-18 |
Pfizer Products Inc. |
Pyrazole compounds
|
|
WO2007120574A2
(en)
*
|
2006-04-11 |
2007-10-25 |
Merck & Co., Inc. |
Diaryl substituted alkanes
|
|
US7807671B2
(en)
|
2006-04-25 |
2010-10-05 |
Bristol-Myers Squibb Company |
Diketo-piperazine and piperidine derivatives as antiviral agents
|
|
US20100168120A1
(en)
|
2006-04-28 |
2010-07-01 |
Neuromedix Inc. |
Salts of pyridazine compounds
|
|
CA2654358A1
(en)
|
2006-06-22 |
2007-12-27 |
Biovitrum Ab (Publ) |
Pyridine and pyrazine derivatives as mnk kinase inhibitors
|
|
DK2120579T3
(da)
|
2006-12-28 |
2014-02-03 |
Abbvie Inc |
Inhibitorer af poly(ADP-ripose)polymerase
|
|
CA2676715A1
(en)
|
2007-02-12 |
2008-08-21 |
Merck & Co., Inc. |
Piperazine derivatives for treatment of ad and related conditions
|
|
JP4785881B2
(ja)
|
2007-02-27 |
2011-10-05 |
大塚製薬株式会社 |
医薬
|
|
CA2687931C
(en)
|
2007-05-31 |
2016-05-24 |
Boehringer Ingelheim International Gmbh |
Ccr2 receptor antagonists and uses thereof
|
|
CA2697077C
(en)
|
2007-08-22 |
2012-10-16 |
Irm Llc |
2-heteroarylamino-pyrimidine derivatives as kinase inhibitors
|
|
CN101801952A
(zh)
|
2007-10-01 |
2010-08-11 |
弗·哈夫曼-拉罗切有限公司 |
用作ccr受体拮抗剂的n-杂环联芳基甲酰胺类化合物
|
|
MX2010003868A
(es)
|
2007-10-09 |
2010-04-27 |
Hoffmann La Roche |
Cis-imidazolinas quirales.
|
|
EP2220045A1
(en)
|
2007-11-20 |
2010-08-25 |
Janssen Pharmaceutica, N.V. |
Substituted pyridyl amide compounds as modulators of the histamine h3 receptor
|
|
CA2705405A1
(en)
|
2007-11-22 |
2009-05-28 |
Boehringer Ingelheim International Gmbh |
New compounds
|
|
EP2062889A1
(de)
|
2007-11-22 |
2009-05-27 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Verbindungen
|
|
EP2297137A1
(en)
|
2008-06-18 |
2011-03-23 |
F. Hoffmann-La Roche AG |
Novel heteroaryl carboxamide derivatives
|
|
JP5693452B2
(ja)
|
2008-08-04 |
2015-04-01 |
シーエイチディーアイ ファウンデーション，インコーポレーテッド |
特定のキヌレニン−３−モノオキシゲナーゼインヒビター、医薬組成物およびそれらの使用方法
|
|
GB0815369D0
(en)
|
2008-08-22 |
2008-10-01 |
Summit Corp Plc |
Compounds for treatment of duchenne muscular dystrophy
|
|
AU2009289378A1
(en)
|
2008-09-02 |
2010-03-11 |
Boehringer Ingelheim International Gmbh |
Novel benzamides, production thereof, and use thereof as medicaments
|
|
HUE025547T2
(en)
|
2008-12-19 |
2016-02-29 |
Boehringer Ingelheim Int |
Cyclic pyrimidine-4-carboxamides as CCR2 receptor antagonists for the treatment of inflammation, asthma and COPD
|
|
CA2750635A1
(en)
|
2009-02-23 |
2010-08-26 |
Merck Canada Inc. |
Heterocyclic derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
|
|
ES2674275T3
(es)
|
2009-12-17 |
2018-06-28 |
Centrexion Therapeutics Corporation |
Antagonistas del receptor CCR2 y usos de los mismos
|
|
US20130143905A1
(en)
|
2009-12-17 |
2013-06-06 |
Boehringer Ingelheim International Gmbh |
Novel antagonists for ccr2 and uses thereof
|
|
EP2569298B1
(en)
|
2010-05-12 |
2015-11-25 |
Boehringer Ingelheim International GmbH |
Novel ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments
|
|
WO2011141477A1
(en)
|
2010-05-12 |
2011-11-17 |
Boehringer Ingelheim International Gmbh |
New ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments
|
|
WO2011144501A1
(en)
|
2010-05-17 |
2011-11-24 |
Boehringer Ingelheim International Gmbh |
Ccr2 antagonists and uses thereof
|
|
EP2576542B1
(en)
|
2010-05-25 |
2015-04-22 |
Boehringer Ingelheim International GmbH |
Cyclic amide derivatives of pyridazine-3-carboxylic acids and their use in the treatment of pulmonary, pain, immune related and cardiovascular diseases
|
|
EP2576538B1
(en)
|
2010-06-01 |
2015-10-28 |
Boehringer Ingelheim International GmbH |
New CCR2 antagonists
|
|
JP5786257B2
(ja)
|
2011-06-16 |
2015-09-30 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
新規の選択的ｃｃｒ２拮抗薬
|
|
EP2731941B1
(en)
|
2011-07-15 |
2019-05-08 |
Boehringer Ingelheim International GmbH |
Novel and selective ccr2 antagonists
|